Likewise, Ikeda et al., (2017) used 3.40 g/dL of albumin to help predict the treatment in poor performance status NSCLC Japanese patients for chemotherapy or best supportive care because the albumin levels associated with their nutritional status affected the survival outcome in those with malnutrition. This evidence concerns the gene ALB and non-small cell lung carcinoma.